Welcome to DukeHealth.org.
Skip over navigation
Skip over navigation
- Home
- Patient and Visitor Info
- Physicians
- Services
- Clinical Trials
- Event Calendar
- Locations
- Health Library
- About Duke Medicine
Quick Links
Home
>
Clinical Trials
>
An Evaluation of the Safety and Efficacy of the Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso
An Evaluation of the Safety and Efficacy of the Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso
Share
This is a multicenter open-label 24-week study to evaluate the safety and tolerability of the addition of UT-15C SR to pulmonary arterial hypertension patients currently receiving Tyvaso.
For more information, contact Melissa Willis, RN at 919-684-6237.
(REF# 30717)
